Mark Guerin
Directeur Financier/CFO chez TRAWS PHARMA, INC.
Fortune : 22 773 $ au 30/04/2024
Postes actifs de Mark Guerin
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| TRAWS PHARMA, INC. | Directeur Financier/CFO | 12/02/2016 | - |
| Comptroller/Controller/Auditor | 09/05/2014 | 12/02/2016 | |
| Directeur des opérations | 10/06/2022 | 01/04/2024 |
Historique de carrière de Mark Guerin
Anciens postes connus de Mark Guerin
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
CardioKine, Inc.
 CardioKine, Inc. Pharmaceuticals: MajorHealth Technology CardioKine, Inc. develops drugs and pharmaceuticals for the treatment and prevention of heart failure. The company was founded by Arthur Michael Feldman, James Mervis, Paul-Andre de Lame and Michael Juliano in 2004 and is headquartered in Pittsburgh, PA. | Directeur Financier/CFO | 01/01/2009 | 01/12/2011 |
Barrier Therapeutics, Inc.
 Barrier Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Barrier Therapeutics, Inc. discovers, develops, and commercializes pharmaceutical products in the field of dermatology in the United States. It markets Xolegel, Vusion, and Solage gels. The firm markets its products to dermatologists and other target physicians through sales force. The company was founded in 2001 and is headquartered in Princeton, NJ | Corporate Officer/Principal | - | - |
Formation de Mark Guerin
| DeSales University | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
Opérationnelle
| Director of Finance/CFO | 2 |
| Comptroller/Controller/Auditor | 1 |
| Chief Operating Officer | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| TRAWS PHARMA, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
CardioKine, Inc.
CardioKine, Inc. Pharmaceuticals: MajorHealth Technology CardioKine, Inc. develops drugs and pharmaceuticals for the treatment and prevention of heart failure. The company was founded by Arthur Michael Feldman, James Mervis, Paul-Andre de Lame and Michael Juliano in 2004 and is headquartered in Pittsburgh, PA. | Health Technology |
Barrier Therapeutics, Inc.
Barrier Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Barrier Therapeutics, Inc. discovers, develops, and commercializes pharmaceutical products in the field of dermatology in the United States. It markets Xolegel, Vusion, and Solage gels. The firm markets its products to dermatologists and other target physicians through sales force. The company was founded in 2001 and is headquartered in Princeton, NJ | Health Technology |
- Bourse
- Insiders
- Mark Guerin
- Expérience
